05705oam 22013454 450 991078766840332120230803031338.01-4843-2239-81-4843-1195-71-4755-1590-1(CKB)2670000000420712(EBL)1588029(SSID)ssj0001076468(PQKBManifestationID)11571679(PQKBTitleCode)TC0001076468(PQKBWorkID)11014905(PQKB)10941992(MiAaPQ)EBC1588029(Au-PeEL)EBL1588029(CaPaEBR)ebr10744787(CaONFJC)MIL509376(OCoLC)868488597(IMF)1FRAEE2013002(IMF)1FRAEA2013002(EXLCZ)99267000000042071220020129d2013 uf 0engurcn|||||||||txtccrFrance : Financial Sector Assessment Program—Detailed Assessment of Observance of Basel Core Principles for Effective Banking SupervisionWashington, D.C. :International Monetary Fund,2013.1 online resource (132 p.)IMF Staff Country ReportsDescription based upon print version of record.1-4755-4195-3 Cover; Contents; Glossary; I. Executive Summary, Key Findings, and Recommendations; A. Introduction; B. Information and Methodology Used for Assessment; C. Institutional and Macroeconomic Setting and Market Structure-Overview; D. Preconditions for Effective Banking Supervision; E. Main Findings; Tables; 1. Summary Compliance with the Basel Core Principles-Detailed Assessments; F. Recommended Action Plan and Authorities' Response; 2. Recommended Action Plan to Improve Compliance with the Basel Core Principles; II. Detailed Assessment; 3. Detailed Assessment of Compliance with the Basel CoreThis paper discusses key findings of the Detailed Assessment of Observance of Basel Core Principles for Effective Banking Supervision for France. The assessment was completed as part of a Financial Sector Assessment Program (FSAP) undertaken by the IMF during 2012. The assessment reveals that France has a well-developed public infrastructure supporting effective banking supervision. It has a complete system of business laws, consistently enforced. Accounting standards for listed companies and other consolidated accounts have been prepared to International Financial Reporting Standards (IFRS), as adopted by the European Union.IMF Staff Country Reports; Country Report ;No. 2013/180Banks and bankingState supervisionFranceFinanceFranceEvaluationBanks and BankingimfMoney and Monetary PolicyimfPublic FinanceimfBanksimfDepository InstitutionsimfMicro Finance InstitutionsimfMortgagesimfTaxation, Subsidies, and Revenue: GeneralimfMonetary Policy, Central Banking, and the Supply of Money and Credit: GeneralimfFinancing PolicyimfFinancial Risk and Risk ManagementimfCapital and Ownership StructureimfValue of FirmsimfGoodwillimfFinancial Institutions and Services: Government Policy and RegulationimfBankingimfPublic finance & taxationimfFinancial services law & regulationimfMonetary economicsimfInternal controlsimfCreditimfOperational riskimfCapital adequacy requirementsimfRevenue administrationimfMoneyimfFinancial regulation and supervisionimfMarket riskimfCredit riskimfBanks and bankingimfRevenueimfFinancial risk managementimfAsset requirementsimfFranceimfBanks and bankingState supervisionFinanceEvaluation.Banks and BankingMoney and Monetary PolicyPublic FinanceBanksDepository InstitutionsMicro Finance InstitutionsMortgagesTaxation, Subsidies, and Revenue: GeneralMonetary Policy, Central Banking, and the Supply of Money and Credit: GeneralFinancing PolicyFinancial Risk and Risk ManagementCapital and Ownership StructureValue of FirmsGoodwillFinancial Institutions and Services: Government Policy and RegulationBankingPublic finance & taxationFinancial services law & regulationMonetary economicsInternal controlsCreditOperational riskCapital adequacy requirementsRevenue administrationMoneyFinancial regulation and supervisionMarket riskCredit riskBanks and bankingRevenueFinancial risk managementAsset requirementsInternational Monetary Fund.DcWaIMFBOOK9910787668403321France299418UNINA04981nam 22006015 450 991014879380332120251116162516.010.1007/978-4-431-56101-9(CKB)3710000000918195(DE-He213)978-4-431-56101-9(MiAaPQ)EBC4730768(PPN)196321476(EXLCZ)99371000000091819520161028d2016 u| 0engurnn|008mamaatxtrdacontentcrdamediacrrdacarrierHepatitis C Virus II Infection and Disease /edited by Tatsuo Miyamura, Stanley M. Lemon, Christopher M. Walker, Takaji Wakita1st ed. 2016.Tokyo :Springer Japan :Imprint: Springer,2016.1 online resource (IX, 372 p. 25 illus., 23 illus. in color.) 4-431-56099-8 4-431-56101-3 Includes bibliographical references at the end of each chapters and index.Part I. Chronic Hepatitis C -- 1. Natural History of chronic hepatitis C (Jake Liang and Marc Ghany) -- 2. The Multifaceted Features of HCV Infection beyond the Liver (Kazuhiko Koike) -- 3. Hepatic Fibrosis in Hepatitis C (Melissa A. Sheiko and Hugo R. Rosen) -- 4. Hepatocellular Carcinoma and Hepatitis C Virus (Sheng-Han Wang, Shiou-Hwei Yeh, and Pei-Jer Chen) -- 5. HCV, Alcohol, and the Liver (Terence N. Bukong, Banishree Saha, and Gyongyi Szabo) -- 6. Extrahepatic Replication of HCV (Wen-Chi Su, Keigo Machida, and Michael M.C. Lai) -- Part II. HCV Infections in Special Populations -- 7. Hepatitis C virus infection in pregnancy and children (Jessica Wen, Samantha Ohmer, Jonathan Honegger) -- Part III. Approaches to Therapy -- 8. Host Genetics and Responses to Antiviral Therapy in Chronic Hepatitis C (Yasuhito Tanaka and Masashi Mizokami) -- 9. Viral Variation and Response to Therapy (Shinya Maekawa and Nobuyuki Enomoto) -- 10. HCV NS3/4A Protease Inhibitors and the Road to Effective Direct-acting Antiviral Therapies (Nicolas Tremblay, Alex Young Park, and Daniel Lamarre) -- 11. Modeling HCV Dynamics in Clinical Practice to Personalize Antiviral Therapy (Piero Colombatto, Ferruccio Bonino, Luigi Civitano, Filippo Oliveri, Gabriele Ricco, Sergio Iannazzo, and Maurizia R. Brunetto) -- Part IV. Prevention and Control of HCV Infection -- 12. Prophylactic Vaccines for the Hepatitis C Virus (Andrea L. Cox) -- 13. Global control of hepatitis C infection (Tatsuo Miyamura).This book helps scientists, clinicians and other interested individuals understand recent clinical advances and challenges for the future. It covers many basic aspects of the pathogenesis of chronic hepatitis C, HCV infections in particular populations, approaches to therapy, and prevention and control of HCV Infection. The book provides a succinct review of the large amount of data generated by multiple groups over the past two decades that has revealed the natural history of HCV infection. Similarly, it summarizes current understanding of the origins of HCV-associated hepatocellular carcinoma, cirrhosis and hepatic fibrosis. Extra-hepatic manifestation and metabolic disorders related to HCV infection are described. In this volume, these clinically important aspects of HCV infection are comprehensively described. Highlights are description of newly developed direct- acting antivirals. The authors represent a worldwide distribution of leaders in the field reflecting the global nature of HCV infection. Based on recent data concerning the genetic- and geographical diversity of HCV, and increased global disease burden of HCV infection, challenges for global control of HCV infections are described.HepatologyVirologyInfectious diseasesPublic healthHepatologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H33088Virologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B22003Infectious Diseaseshttps://scigraph.springernature.com/ontologies/product-market-codes/H33096Public Healthhttps://scigraph.springernature.com/ontologies/product-market-codes/H27002Hepatology.Virology.Infectious diseases.Public health.Hepatology.Virology.Infectious Diseases.Public Health.616.36Miyamura Tatsuoedthttp://id.loc.gov/vocabulary/relators/edtLemon Stanley M.edthttp://id.loc.gov/vocabulary/relators/edtWalker Christopher M.edthttp://id.loc.gov/vocabulary/relators/edtWakita Takajiedthttp://id.loc.gov/vocabulary/relators/edtBOOK9910148793803321Hepatitis C Virus II2527588UNINA